Arianna Draghi

Medicin og biovidenskab

1. Tumor-Infiltrating Lymphocytes 100%
2. T-Lymphocytes 68%
3. Melanoma 48%
4. Neoplasms 44%
5. Immunotherapy 41%
6. c-Mer Tyrosine Kinase 20%
7. tocilizumab 18%
8. Ipilimumab 16%
9. Nivolumab 15%
10. Frameshift Mutation 14%
11. Histocompatibility Antigens Class I 13%
12. Autoantigens 13%
13. Neoplasm Antigens 13%
14. Radiosurgery 12%
15. Antigen Presentation 12%
16. Janus Kinase 1 12%
17. Tumor Microenvironment 11%
18. Adrenal Cortex Hormones 11%
19. In Vitro Techniques 11%
20. Point Mutation 11%
21. Renal Cell Carcinoma 11%
22. Cell- and Tissue-Based Therapy 10%
23. Pancreatic Neoplasms 10%
24. beta 2-Microglobulin 10%
25. Histology 9%
26. Peptides 8%
27. Vaccines 8%
28. Infliximab 8%
29. Neoplasm Metastasis 8%
30. Tumor Necrosis Factor-alpha 8%
31. Dexamethasone 7%
32. Tacrolimus 7%
33. Therapeutics 7%
34. Lymphocyte Activation 7%
35. Artificial Intelligence 6%
36. Clinical Trials 6%
37. Brain 5%